ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
기관지 확장제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에 CAGR은 6.3%를 나타낼 것으로 예측되고 451억 4,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 만성 폐쇄성 폐질환(COPD) 유병률 증가, 연구 개발 노력 확대로 인한 폐질환 치료에 대한 인식 제고, 폐 질환 유병률 증가, 가처분 소득 증가, 흡연율 증가 등에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 첨단 임상 연구 및 혁신적 전략, 기술적 발전 가속화, COPD 및 천식과 같은 폐질환의 높은 유병률, 신제품 출시, 급성 호흡기 감염 환자 수 증가 등이 있습니다.
향후 5년간 6.3% 성장률 전망은 해당 시장에 대한 이전 추정치 대비 0.2% 소폭 하락한 수치입니다. 이러한 하락은 주로 미국과 타국 간 관세 영향 때문입니다. 무역 긴장은 인도 및 멕시코에서 제조된 기관지 확장제 가격 상승을 초래하여 미국 폐질환 클리닉 운영에 차질을 빚을 수 있으며, 결과적으로 만성 폐쇄성 폐질환 관리 옵션 감축 및 호흡기 치료 비용 증가로 이어질 수 있습니다. 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 영향은 더욱 광범위하게 나타날 것입니다.
만성 폐쇄성 폐질환(COPD)의 유병률 증가는 가까운 미래에 기관지 확장제 시장 성장을 촉진할 전망입니다. 기도 만성 염증과 기류 폐쇄 또는 제한을 특징으로 하는 COPD는 전 세계적으로 상당한 건강 문제입니다. 기관지 확장제는 기도 주변 근육을 이완시켜 기도를 열고 호흡 곤란을 완화함으로써 COPD 관리에 핵심적인 역할을 합니다. 예를 들어, 스코틀랜드 공공보건청이 주도한 2023년 3월 스코틀랜드 공중보건 관측소 보고서에 따르면, COVID-19의 영향이 점차 사그라들면서 COPD 발병률이 현저히 증가한 것으로 나타났습니다. 남성의 경우 10만 명당 COPD 환자 비율이 83.2명에서 97.6명으로, 여성은 72.6명에서 97.3명으로 급증했습니다. 결과적으로 COPD 유병률 증가는 기관지 확장제 시장 성장을 촉진하는 주요 요인으로 작용하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 기관지 확장제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 기관지 확장제 시장 : 성장률 분석
세계의 기관지 확장제 시장 실적 : 규모와 성장(2019-2024년)
세계의 기관지 확장제 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 기관지 확장제 : 총 잠재시장 규모(TAM)
제6장 시장 세분화
세계의 기관지 확장제 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
베타-아드레날린 작용성 기관지 확장제
항콜린성 기관지 확장제
크산틴 유도체
기타 유형
세계의 기관지 확장제 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
비강(흡입)
주사제
세계의 기관지 확장제 시장 : 적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
천식
만성 폐쇄성 폐질환(COPD)
알레르기 반응
호흡 곤란
기타 적응증
세계의 기관지 확장제 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
기타 최종 사용자
세계의 기관지 확장제 시장, 베타-아드레날린 작용성 기관지 확장제 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
단시간 작용형 베타 자극제(SABA)
장시간 작용형 베타 자극제(LABA)
세계의 기관지 확장제 시장, 항콜린성 기관지 확장제 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
단시간 작용형 항콜린제
장시간 작용형 항콜린제
세계의 기관지 확장제 시장, 크산틴 유도체 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
테오필린
아미노필린
세계의 기관지 확장제 시장, 기타 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
류코트리엔 수용체 길항제
병용 요법
제7장 지역별, 국가별 분석
세계의 기관지 확장제 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 기관지 확장제 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
기관지 확장제 시장 : 경쟁 구도
기관지 확장제 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson Services Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Thermo Fisher Scientific
Abbott Laboratories
Sanofi SA
GlaxoSmithKline plc
Siemens Healthcare GmbH
Merck & Co. Inc.
AstraZeneca plc
Teva Pharmaceuticals Industries Ltd.
Mylan NV
Quest Diagnostics Incorporated.
Boehringer Ingelheim International GmbH
Aurobindo Pharma Limited
Bio-Rad Laboratories Inc.
Cipla Limited
Hikma Pharmaceutical plc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
기관지 확장제 시장(2029년) : 새로운 기회를 제공하는 국가
기관지 확장제 시장(2029년) : 새로운 기회를 제공하는 부문
기관지 확장제 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Bronchodilators are medications designed to make breathing easier by relaxing the muscles in the lungs and widening the airways (bronchi). They are commonly employed in the treatment of long-term conditions characterized by narrow and inflamed airways, such as asthma and chronic obstructive pulmonary disease (COPD).
The main types of bronchodilators include beta-adrenergic bronchodilators, anticholinergic bronchodilators, xanthine derivatives, and others. Beta-adrenergic bronchodilators, a specific class of medications, function by binding to beta-adrenergic receptors in the smooth muscles of the airways. This binding induces relaxation and dilation of the airways, improving airflow and alleviating symptoms such as wheezing, coughing, and shortness of breath. These bronchodilators can be administered through various routes such as oral, nasal (inhalation), and injectable. They are used for treating conditions such as asthma, COPD, allergic reactions, breathing problems, and other indications. The end users of bronchodilators include hospitals, specialty clinics, and various healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.
The bronchodilators market research report is one of a series of new reports from The Business Research Company that provides bronchodilators market statistics, including bronchodilators industry global market size, regional shares, competitors with a bronchodilators market share, detailed bronchodilators market segments, market trends and opportunities, and any further data you may need to thrive in the bronchodilators industry. This bronchodilators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bronchodilators market size has grown strongly in recent years. It will grow from $32.93 billion in 2024 to $35.31 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growing geriatric population, rising incidence of asthma, growing funding by government organizations, increase in ageing population, and increasing air pollution across the globe.
The bronchodilators market size is expected to see strong growth in the next few years. It will grow to $45.14 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing prevalence of COPD, rising awareness about lung diseases treatment aided with escalating research and development efforts, increase in prevalence of pulmonary disorders, the rise in disposable income, and increasing smoking rates. Major trends in the forecast period include advanced clinical research and innovative strategies, growing technological advancements, high prevalence of lung diseases such as COPD and asthma, new product launches, and rising number of patients with acute respiratory infections.
The forecast of 6.3% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. pulmonary clinics by inflating prices of bronchodilators manufactured in India and Mexico, resulting in reduced chronic obstructive pulmonary disease management management options and higher respiratory care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The escalating prevalence of chronic obstructive pulmonary disease (COPD) is poised to drive the growth of the bronchodilator market in the foreseeable future. COPD, characterized by chronic inflammation of the airways and obstruction or limitation of airflow, represents a significant health challenge globally. Bronchodilators play a crucial role in COPD management by relaxing the muscles around the airways, thereby facilitating the opening of air passages and easing breathing difficulties. For instance, data from a report by the Scottish Public Health Observatory in March 2023, led by Public Health Scotland, revealed a notable increase in COPD rates as the impact of COVID-19 began to subside. The rate of COPD cases per 100,000 individuals surged from 83.2 to 97.6 among males and from 72.6 to 97.3 among females. Consequently, the rising prevalence of COPD serves as a primary driver propelling the growth of the bronchodilator market.
Prominent players in the bronchodilator market are strategically focused on the development of innovative products to cater to evolving patient needs and enhance treatment outcomes. One notable innovation gaining traction is fixed-dose triple-drug combinations-a medication formulation containing three active ingredients in predetermined doses within a single formulation. For example, in January 2023, Lupin, a leading pharmaceutical firm based in India, introduced DIFIZMA, a fixed-dose triple-drug bronchodilator comprising indacaterol, glycopyrronium, and mometasone for asthma management. DIFIZMA, available as a dry powder inhalation, stands out as the sole fixed-dose combination approved by the Drug Controller General of India (DCGI) for inadequately controlled asthma treatment. This innovative formulation demonstrates efficacy in improving lung function, enhancing symptom control, and reducing exacerbations in asthma patients. By offering such advanced solutions, companies such as Lupin aim to address unmet medical needs and contribute to the continued growth and advancement of the bronchodilator market.
In February 2023, AstraZeneca plc, a prominent pharmaceutical and biotechnology company headquartered in the UK, completed the acquisition of CinCor Pharma Inc. for $1.8 billion. This strategic move was driven by the shared goal of developing innovative treatments for uncontrolled hypertension and chronic kidney disease. Additionally, the acquisition is anticipated to bolster AstraZeneca's respiratory portfolio, which encompasses various bronchodilator products. CinCor Pharma, a US-based clinical-stage biopharmaceutical company specializing in the development of bronchodilator-related products, adds valuable expertise to AstraZeneca's endeavors in this therapeutic area.
Major companies operating in the bronchodilators market report are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Thermo Fisher Scientific, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline plc, Siemens Healthcare GmbH, Merck & Co. Inc., AstraZeneca plc, Teva Pharmaceuticals Industries Ltd., Mylan N.V., Quest Diagnostics Incorporated., Boehringer Ingelheim International GmbH, Aurobindo Pharma Limited, Bio-Rad Laboratories Inc., Cipla Limited, Hikma Pharmaceutical plc, Amneal Pharmaceuticals LLC, Glenmark Pharmaceuticals Limited, Vectura Group Limited, Foundation Medicine Inc., Sun Pharmaceutical Industries Ltd., Amgen Inc., Kissei Pharmaceutical Co.Ltd., Mitsubishi Tanabe Pharma, Theron Pharmaceuticals, Viatris Inc.
North America was the largest region in the bronchodilators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bronchodilators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bronchodilators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The bronchodilators market consists of sales of albuterol (proair, ventolin, proventil), formoterol (foradil, perforomist), salmeterol (serevent), tiotropium (spiriva) and ipratropium (atrovent). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bronchodilators Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bronchodilators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bronchodilators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bronchodilators market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Beta-Adrenergic Bronchodilators; Anticholinergic Bronchodilators; Xanthine Derivatives; Other Types
2) By Route of Administration: Oral; Nasal (Inhalation); Injectable
3) By Indication: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Allergic Reactions; Breathing Problem; Other Indications
4) By End-User: Hospitals; Specialty Clinics; Other End Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Bronchodilators Market Characteristics
3. Bronchodilators Market Trends And Strategies
4. Bronchodilators Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Bronchodilators Growth Analysis And Strategic Analysis Framework
5.1. Global Bronchodilators PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bronchodilators Market Growth Rate Analysis
5.4. Global Bronchodilators Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bronchodilators Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bronchodilators Total Addressable Market (TAM)
6. Bronchodilators Market Segmentation
6.1. Global Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Beta-Adrenergic Bronchodilators
Anticholinergic Bronchodilators
Xanthine Derivatives
Other Types
6.2. Global Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Nasal (Inhalation)
Injectable
6.3. Global Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Allergic Reactions
Breathing Problem
Other Indications
6.4. Global Bronchodilators Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Other End Users
6.5. Global Bronchodilators Market, Sub-Segmentation Of Beta-Adrenergic Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Short-Acting Beta Agonists (SABAs)
Long-Acting Beta Agonists (LABAs)
6.6. Global Bronchodilators Market, Sub-Segmentation Of Anticholinergic Bronchodilator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Short-Acting Anticholinergics
Long-Acting Anticholinergics
6.7. Global Bronchodilators Market, Sub-Segmentation Of Xanthine Derivatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Theophylline
Aminophylline
6.8. Global Bronchodilators Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Leukotriene Receptor Antagonists
Combination Therapies
7. Bronchodilators Market Regional And Country Analysis
7.1. Global Bronchodilators Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bronchodilators Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Bronchodilators Market
8.1. Asia-Pacific Bronchodilators Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Bronchodilators Market
9.1. China Bronchodilators Market Overview
9.2. China Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Bronchodilators Market
10.1. India Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Bronchodilators Market
11.1. Japan Bronchodilators Market Overview
11.2. Japan Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Bronchodilators Market
12.1. Australia Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Bronchodilators Market
13.1. Indonesia Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Bronchodilators Market
14.1. South Korea Bronchodilators Market Overview
14.2. South Korea Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Bronchodilators Market
15.1. Western Europe Bronchodilators Market Overview
15.2. Western Europe Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Bronchodilators Market
16.1. UK Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Bronchodilators Market
17.1. Germany Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Bronchodilators Market
18.1. France Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Bronchodilators Market
19.1. Italy Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Bronchodilators Market
20.1. Spain Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Bronchodilators Market
21.1. Eastern Europe Bronchodilators Market Overview
21.2. Eastern Europe Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Bronchodilators Market
22.1. Russia Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Bronchodilators Market
23.1. North America Bronchodilators Market Overview
23.2. North America Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Bronchodilators Market
24.1. USA Bronchodilators Market Overview
24.2. USA Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Bronchodilators Market
25.1. Canada Bronchodilators Market Overview
25.2. Canada Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Bronchodilators Market
26.1. South America Bronchodilators Market Overview
26.2. South America Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Bronchodilators Market
27.1. Brazil Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Bronchodilators Market
28.1. Middle East Bronchodilators Market Overview
28.2. Middle East Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Bronchodilators Market
29.1. Africa Bronchodilators Market Overview
29.2. Africa Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Bronchodilators Market Competitive Landscape And Company Profiles
